Lab on Chip Market Report 2025

The lab on chip market size has grown rapidly in recent years. It will grow from $7.81 billion in 2024 to $8.85 billion in 2025 at a compound annual growth rate (CAGR) of 13.3%. Growth in the historic period was driven by increasing adoption of environmental monitoring, expansion of home-based testing solutions, rising use of companion diagnostics for targeted therapies, higher government funding for pandemic preparedness, and growing demand for veterinary diagnostics.

The lab on chip market size is expected to see rapid growth in the next few years. It will grow to $14.42 billion in 2029 at a compound annual growth rate (CAGR) of 13%. Growth in the forecast period is expected to result from improvements in lab automation and workflow integration, the emergence of wearable lab-on-chip platforms, expansion of clinical trials in low-resource settings, growing interest in synthetic biology applications, and increasing use in food safety testing. Primary trends anticipated for the forecast period include convergence of lab-on-chip and digital health ecosystems, development of biohybrid lab-on-chip systems, adoption of blockchain for lab-on-chip data integrity, rise of subscription-based diagnostic-as-a-service models, and integration of lab-on-chip with CRISPR-based detection.

The increasing use of personalized medicine is expected to drive the growth of the lab-on-chip market due to its ability to provide quick, accurate, and cost-efficient genetic analysis for customized treatments. Personalized medicine tailors prevention and treatment based on an individual’s genetic profile, lifestyle, and environment. The growth of personalized medicine is fueled by advancements in genetic testing, allowing treatments to align with an individual’s genetic makeup, which increases effectiveness and reduces side effects. Lab-on-chip devices facilitate rapid and precise analysis of genetic and molecular data, enabling personalized treatments while lowering both time and costs compared to traditional laboratory techniques. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization in the United States, reported that the FDA approved 16 personalized therapies in 2023 aimed at treating rare diseases, a significant increase from the six treatments approved in 2022. As a result, the expanding use of personalized medicine is boosting the lab-on-chip market.

Companies in the lab-on-chip market are investing in the development of advanced technologies, such as organ-on-chip systems, to speed up disease modeling and enhance applications in personalized medicine. These microfluidic devices mimic human organ functions and structures, offering precise simulations of biological processes for accurate drug testing and disease modeling outside the body. In September 2023, NETRI, a France-based provider of neuro-organs-on-chip technologies, introduced organ-on-chip kits designed to improve preclinical testing speed and predictiveness. By incorporating organ-on-chip systems into healthcare research, these kits support the use of cells from various species, enabling cross-species studies and delivering predictive clinical insights. This development accelerates drug candidate evaluation and reduces the reliance on animal testing, marking a significant advancement in the adoption of organs-on-chip technology in medical research.

In October 2024, Quris-AI, a US-based company focused on AI-driven drug development and safety prediction, acquired Nortis to strengthen its Bio-AI platform. The acquisition, for an undisclosed sum, enables Quris-AI to integrate Nortis’s advanced organ-on-chip technologies into its platform, improving the predictive capabilities for preclinical drug testing. Nortis, based in the United States, is known for its microphysiology systems, including validated kidney-on-chip technologies, which are used in biomedical research and drug development.

Major players in the lab on chip market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd, QuantuMDx Group Ltd., InSphero, Micronit B.V., MesoBioTech, Mimetas, Achira Labs Pvt. Ltd., Elvesys, Beonchip, Lab Chip Technologies, and Sphere Bio.

North America was the largest region in the lab on chip market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lab on chip report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the lab on chip market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

Lab on chip (LOC) is a compact device that integrates multiple laboratory functions, including chemical analysis, biological assays, and diagnostics, onto a single chip. It precisely controls tiny fluid volumes, enabling faster, cost-effective, and high-throughput testing. LOC devices provide portable, efficient, and accurate laboratory analyses while minimizing reagent use and reducing turnaround times.

The primary types of lab on chip products and services include reagents and consumables, instruments, and software and services. Reagents and consumables are essential materials for performing biological and chemical assays. LOC devices employ technologies such as microfluidics, micro-electro-mechanical systems (MEMS), nanolithography, and three-dimensional (3D) printing, using materials such as polymers, glass, silicon, and paper. Applications span genomics, proteomics, point-of-care diagnostics, drug discovery, and other areas. Primary end users include biotechnology and pharmaceutical companies, hospitals, diagnostic centers, academic and research institutes, and others.

The lab on chip market research report is one of a series of new reports that provides lab on chip market statistics, including the lab on chip industry global market size, regional shares, competitors with the lab on chip market share, detailed lab on chip market segments, market trends, opportunities, and any further data you may need to thrive in the lab on chip industry. This lab on chip market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The lab on chip market consists of revenues earned by entities by providing services such as medical diagnostics, drug development and screening, point-of-care testing, and cell and tissue studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab on chip market also includes sales of microfluidic analytical kits, genetic testing chips, organ-on-a-chip systems, and environmental monitoring chips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.